Website Under Construction
The Atmo Gas Capsule System measures whole gut and regional gut (stomach, small bowel, and colon) transit times. Measurements of gastrointestinal tract transit times are used for evaluating motility disorders such as gastroparesis and slow transit constipation.
The Atmo Gas Capsule System is pending FDA 510(k) clearance and is not available for sale.
Image for illustration purposes only. Actual product may differ in appearance.
Gut disorders are common and debilitating
More than 40% of people worldwide are expected to suffer from a functional gut disorder1. Functional gut disorders are challenging to manage and a third of patients are expected to remain undiagnosed or suffer from recurrence.
These disorders are characterized by chronic symptoms such as abdominal pain, dysphagia, dyspepsia, diarrhea, constipation and bloating. This condition is caused by disorders of gastrointestinal (GI) function, including dysmotility.
Motility refers to the rate that food contents move through the regions of the gut. Delayed gastric emptying and slow transit constipation are dysmotility conditions. The Atmo Capsule uses data from gas sensors and other onboard sensors to determine its location in the gastrointestinal tract to measure gut motility.
1. Sperber et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study, Gastroenterology, 2021
A simple, easy-to-use solution
The Atmo Gas Capsule is an ingestible capsule that measures gases directly at the source of production in the gastrointestinal tract (GI tract) and transmits the data wirelessly.
The Atmo Gas Capsule System measures whole gut and regional gut (stomach, small bowel, and colon) transit times. Measurements of gastrointestinal tract transit times are used for evaluating motility disorders such as gastroparesis and slow transit constipation.
Transit times are derived from measures of temperature, hydrogen concentration, carbon dioxide concentration, along with indicators of oxygen level, capsule tumble, and antenna reflectance.
The Capsule can electronically report important data from these measures and wirelessly transmits the data which can be uploaded to the Cloud for aggregation, analysis and patient reporting.
How the Atmo Gas Capsule works
News
-
Atmo Biosciences reaches primary endpoints in pivotal clinical study for initial indication
April 9, 2024. Atmo Biosciences is delighted to report that it has successfully reached its primary endpoints in a pivotal clinical study to assess whole and regional gut transit time in subjects with...
-
Atmo Biosciences achieves patient recruitment target for dysmotility pivotal clinical study
December 14, 2023. Atmo Biosciences has reached its patient recruitment target ahead of schedule for its dysmotility pivotal clinical study. More than 200 patients were recruited in a multi-site clini...
Medical Advisory Board
Prof. Eamonn Quigley (Chair)
David M. Underwood Chair of Medicine in Digestive Disorders and Chief of Gastroenterology and Hepatology.
Houston Methodist Hospital
Prof. Peter Gibson
Affiliated with
Monash University
Prof. William D. Chey
Chief of Gastroenterology and Hepatology.
University of Michigan
Prof. Satish Rao
Distinguished University Chair in Gastroenterology & Professor of Medicine. Director, Neurogastroenterology/Motility and Digestive Health Clinical Research Center.
Augusta University
Prof. Lin Chang
Professor of Medicine, Vice-Chief of the Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine.
David Geffen School of Medicine at UCLA
Prof. Anthony Lembo
Director of Research for Digestive Disease & Surgery Institute.
Cleveland Clinic
Assoc. Prof. Braden Kuo
Director of Center for Neurointestinal Health at Massachusetts General Hospital and Associate Professor at Harvard Medical School.
Board
Malcolm Hebblewhite
President & CEO, Co-Founder
Kate Hill
Chair of the Board & Non-Executive Director
Dr. Chris Roberts AO
Non-Executive Director
Chris Bertrand
Non-Executive Director
Leadership
Dr. Kyle Berean
Head of Clinical Affairs & Co-Founder
Dr. James John
Head of Research and Development/Product Development & Co-Founder
Dr. Carl Runde
Chief Financial Officer & Company Secretary
Sue Dafnias
Head of Commercial
Tajanka Mladenovska
Quality Assurance/Regulatory Affairs Manager
Matt Reeves
Manufacturing Manager
